Search Results for: Polyrizon

Allergy-blocking nasal spray is safe

Israel’s Polyrizon (see here previously) announced the successful preliminary safety study for a formulation of its PL-14 Allergy Blocker, marking a significant advancement in the product’s development path. https://www.nasdaq.com/articles/polyrizon-ltd-announces-successful-preliminary-safety-study-pl-14-allergy-blocker

Posted in Israel's Medical Achievements | Leave a comment

Startup investment – to 1/12/24

Eon.io raised $70 million; Pyramid Analytics (already a Unicorn) raised $50 million from BlackRock; Appcharge raised $26 million (plus $5 million seed); Decart raised $25 million; Capitolis raised $20 million; Polyrizon raised $4.2 million (IPO);

Posted in Economy & Business | Leave a comment

Nasal therapy delivery

Israel’s Polyrizon is developing innovative medical device hydrogels delivered in the form of nasal sprays. These can trap incoming pathogens to protect individuals, but also deliver medicines efficiently into the bloodstream to treat disease. Polyrizon has raised $4.2 million on … Continue reading

Posted in Israel's Medical Achievements | Leave a comment